Aortic Stenosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) the presence of symptoms; (2) the presence of degenerative AS; (3) a mean gradient of >40 mm Hg or a jet velocity of >4.0 m/s; and/or (4) an aortic valve area <1.0 cm2 (or an effective orifice area index <0.6 cm2/m2).
Exclusion criteria
Exclusion criteria: (1) presence of a non-calcified aortic valve; (2) failed surgical bioprosthesis implantation; (3) presence of severe aortic regurgitation; and/or (4) the current use of dialysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality and incidence of heart failure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Peri- and post-procedural any kind of adverse clinical events including death, cerebrovascular events such as stroke, bleeding, heart failure with or without hospitalization, and other TAVI-related complications. | — |
Countries
Japan
Contacts
Osaka City University Graduate School of Medicine Cardiovascular Medicine